Chemed Valuation
| CXM Stock | EUR 392.00 2.00 0.51% |
At this time, the firm appears to be overvalued. Chemed shows a prevailing Real Value of €317.52 per share. The current price of the firm is €392.0. Our model approximates the value of Chemed from analyzing the firm fundamentals such as return on equity of 0.35, and Profit Margin of 0.12 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Chemed's price fluctuation is very steady at this time. Calculation of the real value of Chemed is based on 3 months time horizon. Increasing Chemed's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Chemed stock is determined by what a typical buyer is willing to pay for full or partial control of Chemed. Since Chemed is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Chemed Stock. However, Chemed's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 392.0 | Real 317.52 | Hype 392.0 | Naive 398.35 |
The real value of Chemed Stock, also known as its intrinsic value, is the underlying worth of Chemed Company, which is reflected in its stock price. It is based on Chemed's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Chemed's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Chemed helps investors to forecast how Chemed stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Chemed more accurately as focusing exclusively on Chemed's fundamentals will not take into account other important factors: Chemed Total Value Analysis
Chemed is currently estimated to have takeover price of 7.54 B with market capitalization of 7.23 B, debt of 92.5 M, and cash on hands of 3.32 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Chemed fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
7.54 B | 7.23 B | 92.5 M | 3.32 M |
Chemed Investor Information
About 95.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 2.52. Chemed recorded earning per share (EPS) of 15.57. The entity last dividend was issued on the 24th of February 2023. Based on the measurements of operating efficiency obtained from Chemed's historical financial statements, Chemed is not in a good financial situation at the moment. It has a very high risk of going through financial straits in August.Chemed Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Chemed has an asset utilization ratio of 148.05 percent. This implies that the Company is making €1.48 for each dollar of assets. An increasing asset utilization means that Chemed is more efficient with each dollar of assets it utilizes for everyday operations.Chemed Ownership Allocation
The market capitalization of Chemed is €7.23 Billion. The majority of Chemed outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Chemed to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Chemed. Please pay attention to any change in the institutional holdings of Chemed as this could imply that something significant has changed or is about to change at the company. Note, that even with substantial debt, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company at some point.Chemed Profitability Analysis
The company reported the revenue of 2.13 B. Net Income was 249.62 M with profit before overhead, payroll, taxes, and interest of 765.09 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Chemed's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Chemed and how it compares across the competition.
About Chemed Valuation
The stock valuation mechanism determines Chemed's current worth on a weekly basis. Our valuation model uses a comparative analysis of Chemed. We calculate exposure to Chemed's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Chemed's related companies.Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. Chemed Corporation was founded in 1970 and is headquartered in Cincinnati, Ohio. CHEMED CORP operates under Medical Care classification in Germany and is traded on Frankfurt Stock Exchange. It employs 15707 people.
8 Steps to conduct Chemed's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Chemed's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Chemed's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Chemed's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Chemed's revenue streams: Identify Chemed's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Chemed's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Chemed's growth potential: Evaluate Chemed's management, business model, and growth potential.
- Determine Chemed's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Chemed's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Chemed Stock analysis
When running Chemed's price analysis, check to measure Chemed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemed is operating at the current time. Most of Chemed's value examination focuses on studying past and present price action to predict the probability of Chemed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemed's price. Additionally, you may evaluate how the addition of Chemed to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |